IL22RA2 and inflammatory bowel disease: For example, patients with active IBD on anti-TNFα therapy that responded to that therapy had undetectable levels of IL22RA2 in T cells and DCs isolated from biopsies, compared with the patients that did not respond to anti-TNFα therapy (28).